Prof Davy Koech reveals how KEMRI was started and why KEMRON was rejected

Prof. Davy Kiprotich Koech looks back and reveals the pain, blood and tears that went into setting up KEMRI and why he refused to renew the patent for KEMRON, a drug KEMRI had developed to treat and manage HIV/AIDS.

Prof. Davy Kiprotich Koech is a Chief Research Officer, founder member(1979) and the 3rd Director & Chief Executive of the Kenya Medical Research Institute (KEMRI). [Wilberforce Okwiri, Standard]

Prof Davy Koech shudders each time he recalls his childhood and his hospitalisation with a broken leg. The excruciating pain and humiliation he suffered on that hospital bed as a 10-year-old still gnaws at his soul.